Literature DB >> 9895305

L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity?

A Verri1, A Montecucco, G Gosselin, V Boudou, J L Imbach, S Spadari, F Focher.   

Abstract

We demonstrate that l-ATP is recognized by some enzymes that are involved in the synthesis of nucleotides and nucleic acids. l-ATP, as well as its natural d-enantiomer, acts as a phosphate donor in the reaction catalysed by human deoxycytidine kinase, whereas it is not recognized by either enantioselective human thymidine kinase or non-enantioselective herpes virus thymidine kinase. l-ATP strongly inhibits (Ki 80 microM) the synthesis of RNA primers catalysed by DNA primase associated with human DNA polymerase alpha, whereas RNA synthesis catalysed by Escherichia coli RNA polymerase is completely unaffected. Moreover, l-ATP competitively inhibits ATP-dependent T4 DNA ligase (Ki 25 microM), suggesting that it interacts with the ATP-binding site of the enzyme. Kinetic studies demonstrated that l-ATP cannot be used as a cofactor in the ligase-catalysed joining reaction. On the other hand, l-AMP is used by T4 DNA ligase to catalyse the reverse reaction, even though a high level of intermediate circular nicked DNA molecules accumulates. Our results suggest that a lack of enantioselectivity of enzymes is more common than was believed a few years ago, and, given the absence of selective constraints against l-nucleosides in Nature, this may depend on chance more than on evolutionary strategy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9895305      PMCID: PMC1220013     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro.

Authors:  J A Coates; N Cammack; H J Jenkinson; I M Mutton; B A Pearson; R Storer; J M Cameron; C R Penn
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Evolution of herpesvirus thymidine kinases from cellular deoxycytidine kinase.

Authors:  P T Harrison; R Thompson; A J Davison
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

3.  Molecular basis for the antiviral and anticancer activities of unnatural L-beta-nucleosides.

Authors:  S Spadari; G Maga; A Verri; F Focher
Journal:  Expert Opin Investig Drugs       Date:  1998-08       Impact factor: 6.206

4.  Use of ATP, dATP and their alpha-thio derivatives to study DNA ligase adenylation.

Authors:  A Montecucco; M Lestingi; G Pedrali-Noy; S Spadari; G Ciarrocchi
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

5.  Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.

Authors:  J Balzarini; E De Clercq; H Baumgartner; M Bodenteich; H Griengl
Journal:  Mol Pharmacol       Date:  1990-03       Impact factor: 4.436

6.  N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase.

Authors:  F Focher; C Hildebrand; S Freese; G Ciarrocchi; T Noonan; S Sangalli; N Brown; S Spadari; G Wright
Journal:  J Med Chem       Date:  1988-08       Impact factor: 7.446

7.  Nucleoside analogs as non-substrate inhibitors of herpes simplex viruses thymidine kinase.

Authors:  F Focher; D Sandoli; C Hildebrand; S Sangalli; G Ciarrocchi; A Rebuzzini; G Pedrali-Noy; R Manservigi; G Wright; N Brown
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989-09

8.  Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents.

Authors:  C N Chang; V Skalski; J H Zhou; Y C Cheng
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

9.  The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.

Authors:  P A Furman; M Davis; D C Liotta; M Paff; L W Frick; D J Nelson; R E Dornsife; J A Wurster; L J Wilson; J A Fyfe
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth.

Authors:  S Spadari; G Maga; F Focher; G Ciarrocchi; R Manservigi; F Arcamone; M Capobianco; A Carcuro; F Colonna; S Iotti
Journal:  J Med Chem       Date:  1992-10-30       Impact factor: 7.446

View more
  4 in total

1.  Inhibition of guanosine monophosphate synthetase by the substrate enantiomer L-XMP.

Authors:  Nicholas B Struntz; Tianshun Hu; Brian R White; Margaret E Olson; Daniel A Harki
Journal:  Chembiochem       Date:  2012-10-23       Impact factor: 3.164

2.  Internal 32P-labeling of L-deoxyoligonucleotides.

Authors:  Christian Frauendorf; Felix Hausch; Ingo Röhl; Andrea Lichte; Stefan Vonhoff; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

3.  Entrapment of glucose oxidase within gold converts it to a general monosaccharide-oxidase.

Authors:  Yael Baruch-Shpigler; David Avnir
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

4.  A novel route to a chiral building block for the preparation of cyclopentenyl carbocyclic nucleosides. Synthesis and anticancer activity of enantiomeric neplanocins A.

Authors:  Beata Łukasik; Maciej Mikina; Marian Mikołajczyk; Róża Pawłowska; Remigiusz Żurawiński
Journal:  RSC Adv       Date:  2020-08-27       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.